Clinical Trials Browser

Phase 2 × Terminated × glasdegib × Clear all

NCT04051996 2021-10-15

GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia

Phase 2 Terminated

1 enrolled 4 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute